Pandemic Is Likely to Alter Autoimmune Disorder Care Delivery

As a result of the COVID-19 pandemic, patients with autoimmune disorders who depend on caregiver-administered drugs face serious challenges to their safety, according to a recent analysis published by Avalere Health. Many patients who need to visit a clinical site to receive treatment for autoimmune disorders are confronted with a difficult choice: go out in public to face the danger of a virulent, fast-spreading pandemic for which they are at acute risk, or stay home and go without their medication.

“[Immunocompromised] patients are experiencing this maybe more acutely than any of us,” Lance Grady, a managing director at Avalere and one of the authors of the white paper, tells AIS Health. “For a patient to have to sit in their home and have a telehealth engagement with their provider, that’s a new experience. Then for a patient to go through a workup with their provider and understand what other therapeutic alternatives might be available, or what the next steps are in care — typically these are interventions that require a patient to ambulate. A patient would then have to say, ‘Is it safe for me to go out there?’”

© 2021 MMIT

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/09/Drug_Benefits_Life_Sciences.jpg
November 23

Will ‘Build Back Better’ Spell Disaster for Pharma Innovation?

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured-Image-health-plan-weekly-Wall-Street-Isnt-Sweating-Cignas-Third-Quarter-MLR-Miss.jpg
November 23

Big Three PBMs’ 3Q Results Make Up for Insurer Disappointments

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/11/WordPress-Featured_AdobeStock_442155384.jpg
November 23

SCAN Health Opts to Invest in Medication Adherence Tool

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today